Serology is currently the method of choice for the laboratory diagnosis of Lyme borreliosis, but it must be interpreted with caution. A total of 954 patients with suspected Lyme borreliosis were evaluated on the basis of clinical and serological data. The seroprevalence of Borrelia burgdorferi antibodies was 4.4% (42 of the 954 serum samples). The most frequent clinical manifestation was erythema migrans which occurred in 50% of the seropositive patients, followed by neuroborreliosis (16.6%) and arthritis (11.9%). Carditis was rare. Our findings suggest that for the diagnosis of Lyme borreliosis, serologic tests need to be combined with clinical signs and symptoms.
SteereAC. Lyme disease. N Eng J Med1989; 321: 586–96.
2.
StanekGStrleF. Lyme borreliosis - European perspective. Infect Dis Clin North Am2008; 22:327–39.
3.
SantinoIBerluttiFPantanellaFSessaRDel PianoM. Detection of Borrelia burgdorferi sensu lato DNA by Polymerase Chain Reaction in serum of patients with clinical symptoms of Lyme borreliosis. FEMS Microbiol Lett2008; 283:30–5.
4.
Collares-PereiraMCouceiroSFrancaI. First isolation of Borrelia lusitaniae from a human patient. J Clin Microbiol2004; 42:1316–8.
5.
StanekGFingerleVHunfeldKP. Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect2011; 17:69–79.
6.
Aguero-RosenfeldMEWangGSchwartzIWormserGP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev2005; 18:484–509.
7.
SantinoIGrilloRNicolettiMSantapaolaDSpezialeDSessaRFaddaGDel PianoM. Prevalence of IgG antibodies against Borrelia burgdorferi s. 1. and Ehrlichia phagocytophila in sera of patients presenting symptoms of Lyme disease in a central region of Italy. Int J Immunopathol Pharmacol2002; 15:245–8.
8.
LipskerDHansmannYLimbachF. Disease expression of Lyme borreliosis in northeastern france. Eur J Clin Microbiol Infect Dis2001; 20:225–30.
9.
SkogmanBHEkerfeltCLudvigssonJForsbergP. Seroprevalence of Borrelia IgG antibodies among young children in relation to reported tick bites, sympoms and previous treatment for Lyme borreliosis: a population-based survey. Arch Dis Child2010; 95:1013–16.
10.
DhoteRBasse-GuerineauALBeaumesnilVChristoforovBAssousMV. Full spectrum of clinical, serological, and epidemiological features of complicated forms of Lyme borreliosis in the Paris, France, area. Eur J Clin Microbiol Infect Dis2000; 19:809–15.
11.
ChristovaIKomitovaR. Clinical and epidemiological features of Lyme borreliosis in Bulgaria. Wien Klin Wochenschr2004; 116:42–6.
12.
CoxJKrajdenM. Cardiovascular manifestations of Lyme disease. Am Heart J1991; 122:1449–55.
13.
Van der LindeMR. Lyme carditis: clinical characteristics of 105 cases. Scand J Infect Dis1991; 77:81–4.
14.
BerglundJEitremROmsteinK. An epidemiological study of Lyme diseases in southern Sweden. N Eng J Med1995; 333:1319–27.
15.
CimminoMA. Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe. European Community Concerted Action on Risk Assessment in Lyme borreliosis. Infection1998; 2:298–300.
16.
BarantonGPosticDSaint GironsIBoerlinPPiffaretfiJCAssousMVGrimontPA. Delineation of Borrelia burgdorferi sensu stricto, Borretia garinii sp. nov. and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol1992; 42:378–83.
17.
KimuraKIsogaiEIsogaiHNishikawaTMasuzawaTYoshikawaKKotakeSOhnoSFujiiN. Prevalence of antibodies against Borrelia species in patients with unclassified uveitis in regions in which Lyme disease is endemic and non endemic. Clin Diagn Lab Immunol1995; 2:53–6.
18.
OksiJMarttilaHSoiniHAhoHUksilaJMattiKV. Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS2001; 109:581–88.
19.
WalkerDH. Tick-transmitted infectious diseases in the United States. Annu Rev Public Health1998; 19: 237–69.
